Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Gary L. Pattee, Angela Genge, Philippe Couratier, Christian Lunetta, Gen Sobue, Masashi Aoki, Hiide Yoshino, Carlayne E. Jackson, James Wymer, Alejandro Salah & Sally Nelson. (2023) Oral Edaravone – Introducing a Flexible Treatment Option for Amyotrophic Lateral Sclerosis. Expert Review of Neurotherapeutics 0:0, pages 1-8.
Read now
Read now
Paul Mehta, Jaime Raymond, Reshma Punjani, Moon Han, Theodore Larson, Wendy Kaye, Lorene M. Nelson, Barbara Topol, Oleg Muravov, Corina Genson & D. Kevin Horton. (2023) Prevalence of amyotrophic lateral sclerosis in the United States using established and novel methodologies, 2017. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:1-2, pages 108-116.
Read now
Read now
Betts Peters, Kerth O’Brien & Melanie Fried-Oken. (2022) A recent survey of augmentative and alternative communication use and service delivery experiences of people with amyotrophic lateral sclerosis in the United States. Disability and Rehabilitation: Assistive Technology 0:0, pages 1-14.
Read now
Read now
Jaime Raymond, Paul Mehta, Ted Larson, Pam Factor-Litvak, Bryn Davis & Kevin Horton. (2021) History of vigorous leisure-time physical activity and early onset amyotrophic lateral sclerosis (ALS), data from the national ALS registry: 2010–2018. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:7-8, pages 535-544.
Read now
Read now
Sarah Opie-Martin, Lynn Ossher, Andrea Bredin, Anna Kulka, Neil Pearce, Kevin Talbot & Ammar Al-Chalabi. (2021) Motor Neuron Disease Register for England, Wales and Northern Ireland—an analysis of incidence in England. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:1-2, pages 86-93.
Read now
Read now
Jaime Raymond, BjÖrn Oskarsson, Paul Mehta & Kevin Horton. (2019) Clinical characteristics of a large cohort of US participants enrolled in the National Amyotrophic Lateral Sclerosis (ALS) Registry, 2010–2015. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:5-6, pages 413-420.
Read now
Read now
Rituparna Bhattacharya, Raymond A. Harvey, Keli Abraham, Jon Rosen & Paul Mehta. (2019) Amyotrophic lateral sclerosis among patients with a Medicare Advantage prescription drug plan; prevalence, survival and patient characteristics. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:3-4, pages 251-259.
Read now
Read now
Articles from other publishers (9)
Betts Peters, Jack Wiedrick & Carolyn Baylor. (2023) Effects of Aided Communication on Communicative Participation for People With Amyotrophic Lateral Sclerosis. American Journal of Speech-Language Pathology 32:4, pages 1450-1465.
Crossref
Crossref
Meifang Li, Xun Shi, Jiang Gui, Chao Song, Angeline S. Andrew, Erik P. Pioro, Elijah W. Stommel, Maeve Tischbein & Walter G. Bradley. (2022) A new method for estimating under-recruitment of a patient registry: a case study with the Ohio Registry of Amyotrophic Lateral Sclerosis. Scientific Reports 12:1.
Crossref
Crossref
Lorene M. Nelson, Barbara Topol, Wendy Kaye, Jaime Raymond, D. Kevin Horton, Paul Mehta & Todd Wagner. (2022) Evaluation of the Completeness of ALS Case Ascertainment in the US National ALS Registry: Application of the Capture-Recapture Method. Neuroepidemiology 56:2, pages 104-114.
Crossref
Crossref
Suzanne F. Cook, Thomas Rhodes, Courtney Schlusser, Steve Han, Chao Chen, Neta Zach, Venkatesha Murthy & Shreya Davé. (2021) A Descriptive Review of Global Real World Evidence Efforts to Advance Drug Discovery and Clinical Development in Amyotrophic Lateral Sclerosis. Frontiers in Neurology 12.
Crossref
Crossref
Jaime Raymond, Paul Mehta, Ted Larson, Erik P. Pioro & D. Kevin Horton. (2021) Reproductive History and Age of Onset for Women Diagnosed with Amyotrophic Lateral Sclerosis: Data from the National ALS Registry: 2010–2018. Neuroepidemiology 55:5, pages 416-424.
Crossref
Crossref
Benjamin Rix Brooks & Jerome E. Kurent. 2021. Public Policy in ALS/MND Care. Public Policy in ALS/MND Care
301
326
.
Sandra Carrera-Juliá, Mari Luz Moreno, Carlos Barrios, Jose Enrique de la Rubia Ortí & Eraci Drehmer. (2020) Antioxidant Alternatives in the Treatment of Amyotrophic Lateral Sclerosis: A Comprehensive Review. Frontiers in Physiology 11.
Crossref
Crossref
Lindsay Rechtman, Heather Jordan, Wendy Kaye, Maggie Ritsick & Paul Mehta. (2018) Increasing Patient Self-Enrollment in the National Amyotrophic Lateral Sclerosis Registry: Lessons Learned From a Direct to Provider Campaign. Journal of Patient Experience 7:1, pages 71-82.
Crossref
Crossref
Paul MehtaWendy KayeJaime RaymondReshma PunjaniTheodore LarsonJessica CohenOleg MuravovKevin Horton. (2018) Prevalence of Amyotrophic Lateral Sclerosis — United States, 2015. MMWR. Morbidity and Mortality Weekly Report 67:46, pages 1285-1289.
Crossref
Crossref